IXHL News and Press, Incannex Healthcare Limited

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 4.2% to $1.59 on volume of 363,266,929 shares XWELL Inc. (XWEL) rose 220.1% to $1.21 on volume of 352,958,775 shares Classover Holdings Inc. (KIDZ) rose 13.4% to $0.1085 on volume ...

A look at the top 10 most actives in the United States XWELL Inc. (XWEL) rose 222.8% to $1.22 on volume of 330,501,169 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 4.8% to $1.58 on volume of 298,228,172 shares Classover Holdings Inc. (KIDZ) rose 14.4% to $0.1095 on volume ...

2026-02-25 10:36:30 ET More on Incannex Healthcare Seeking Alpha’s Quant Rating on Incannex Healthcare Historical earnings data for Incannex Healthcare Financial information for Incannex Healthcare Read the full article on Seeking Alpha For fur...

MELBOURNE, Australia and NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc . (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage pharmaceutical company developing innovative combination therapies for high-impact medical conditions, to...

Dallas, Texas--(Newsfile Corp. - February 18, 2026) - Incannex Healthcare Inc. (NASDAQ: IXHL): Stonegate Capital Partners updates their coverage on Incannex Healthcare Inc. (NASDAQ: IXHL). Incannex continued to build the clinical and patient-reported evidence base for IHL-42X in obstructive sleep...

Air Canada Inc. (ACDVF) is expected to report $0.2 for Q4 2025 Edesa Biotech Inc. (EDSA) is expected to report $-0.28 for Q1 2026 Advance Auto Parts Inc. (AAP) is expected to report $0.41 for Q4 2025 Neuphoria Therapeutics Inc. (NEUP) is expected to report $-0.56 for Q2 2026 Kirin...

Incannex Healthcare Inc. (IXHL) is expected to report $-0.02 for Q2 2026

MELBOURNE, Australia and NEW YORK, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced the appointment of three additional members to its recently established Clinical Ad...

MELBOURNE, Australia and NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, announces the formation of a Clinical Advisory Board (CAB) to support the continued advancement of ...

MELBOURNE, Australia and NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced that it has been honored with the  Research and Development Award in the Respi...